NM_001007561.3:c.1798G>A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001007561.3(IRGQ):​c.1798G>A​(p.Val600Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

IRGQ
NM_001007561.3 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.08

Publications

0 publications found
Variant links:
Genes affected
IRGQ (HGNC:24868): (immunity related GTPase Q) Predicted to enable GTP binding activity. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3009683).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRGQNM_001007561.3 linkc.1798G>A p.Val600Ile missense_variant Exon 3 of 3 ENST00000422989.6 NP_001007562.1 Q8WZA9
IRGQNM_001388309.1 linkc.1798G>A p.Val600Ile missense_variant Exon 3 of 3 NP_001375238.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRGQENST00000422989.6 linkc.1798G>A p.Val600Ile missense_variant Exon 3 of 3 5 NM_001007561.3 ENSP00000387535.1 Q8WZA9
IRGQENST00000602269.2 linkc.1798G>A p.Val600Ile missense_variant Exon 2 of 2 1 ENSP00000472250.1 Q8WZA9
ENSG00000268361ENST00000594374.1 linkc.168+768G>A intron_variant Intron 1 of 2 3 ENSP00000472698.1 M0R2N6
IRGQENST00000601520.1 linkn.251+657G>A intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
244718
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1460070
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
2
AN XY:
726364
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33478
American (AMR)
AF:
0.00
AC:
0
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26094
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86214
European-Finnish (FIN)
AF:
0.0000192
AC:
1
AN:
52056
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111710
Other (OTH)
AF:
0.00
AC:
0
AN:
60350
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.013624), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 17, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1798G>A (p.V600I) alteration is located in exon 3 (coding exon 2) of the IRGQ gene. This alteration results from a G to A substitution at nucleotide position 1798, causing the valine (V) at amino acid position 600 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.010
T;T
Eigen
Uncertain
0.28
Eigen_PC
Benign
0.19
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.59
T;.
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.30
T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.6
L;L
PhyloP100
1.1
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
0.070
N;.
REVEL
Benign
0.16
Sift
Benign
0.16
T;.
Sift4G
Benign
0.30
T;T
Polyphen
1.0
D;D
Vest4
0.11
MutPred
0.46
Gain of catalytic residue at L605 (P = 0.0317);Gain of catalytic residue at L605 (P = 0.0317);
MVP
0.43
ClinPred
0.67
D
GERP RS
4.9
Varity_R
0.060
gMVP
0.18
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1208538553; hg19: chr19-44096252; API